Healthcare CEO Discusses an Imaging Agent That Lights Up Lung Cancer During Surgery
On Target Laboratories recently announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded indication for the use of CYTALUX™
On Target Laboratories recently announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded indication for the use of CYTALUX™
The FDA granted approval to tisotumab vedotin-tftv for the treatment of recurrent or metastatic cervical cancer.
A brief episode of anger triggered by a past experience has the potential to increase the risk of stroke by weakening the ability of blood…
Dr. Marisa Bittoni discusses the possible link between vaping and lung cancer risk.
Patient-derived organoids have shown promise in modeling cancer therapy response.
There is increasing interest in the use of musculoskeletal ultrasound in pediatric rheumatology.
Drs. Nabhan and Ahluwalia delve into the latest breakthroughs in primary brain cancers and discuss advancements in survival rates, promising therapeutic agents, and more.
Cancer organoid-based drug sensitivity tests have recently been investigated to predict responses to anticancer drugs.
A study that assessed the impact of miR-29a and miR-143 on gene expression in lung cancer.
A study that examined whether the combination of AI and knowledge can identify more patients with lung and ovarian cancers.
A gene model has the potential to serve as a prognostic indicator for patients with head and neck squamous cell carcinoma.